Currently approved anticoagulants for treatment of patients with coronary artery disease manifestations include unfractionated heparin, low-molecular-weight heparins, bivalirudin, and fondaparinux.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback